Are all NSAIDs other than 'coxibs' really equal?

Trends in Pharmacological Sciences

Volumn 25, Issue 1, 2004, Pages 6-7

  Bianchi, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC; ETORICOXIB; LUMIRACOXIB; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; VALDECOXIB;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTHRALGIA; DRUG CLASSIFICATION; DRUG COST; DRUG DESIGN; DRUG MARKETING; DRUG QUALITY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TOXICITY; HUMAN; LETTER; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0347915573     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2003.11.004     Document Type: Letter

References (11)

1. Steinmeyer J. Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs. Arthritis Res. 2:2000;379-385.
2. Hinz B., Brune K. Cyclooxygenase-2-10 years later. J. Pharmacol. Exp. Ther. 300:2002;367-375.
3. Schumacher H.R. The promise of coxibs: how far have we progressed? J. Pain Symptom Manage. 23:2002;S1-S4.
4. Flower R.J. The development of COX2 inhibitors. Nat. Rev. Drug Discov. 2:2003;179-191.
5. Vane J.R. Towards a better aspirin. Nature. 367:1994;215-216.
6. Vane J.R., Botting R.M. New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res. 44:1995;1-10.
7. Frölich J.C. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol. Sci. 18:1997;30-34.
8. Warner T.D., et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7563-7568.
9. Jones R.A. Etodolac: clinical profile of an established selective cyclo-oxygenase-2 inhibitor. Vane J.R., Botting R.M. Therapeutic Roles of Selective COX-2 Inhibitors. 2001;482-497 William Harvey Press, London.
10. Degner F., et al. Pharmacological and clinical profile of meloxicam. Vane J.R., Botting R.M. Therapeutic Roles of Selective COX-2 Inhibitors. 2001;498-523 William Harvey Press, London.
11. Bennett A. Nimesulide: a well-established cyclooxygenase-2 inhibitor with many other pharmacological properties relevant to inflammatory diseases. Vane J.R., Botting R.M. Therapeutic Roles of Selective COX-2 Inhibitors. 2001;524-540 William Harvey Press, London.